Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 91-98

  Acharya, G P ^a   Davis, T M E ^b,e   Ho, M ^c   Harris, S ^a   Chataut, C ^a   Acharya, S ^a   Tuhladar, N ^a   Kafle, K E ^a   Pokhrel, B ^a   Nosten, F ^b   Dance, D A B ^b   Smith, A ^d   Weber, A ^d   White, N J ^b  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALGARY   (Canada)

^d University of Missouri   (United States)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; INDOCYANINE GREEN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; FEVER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN RESIDENCE TIME; NEPAL; PLASMA CLEARANCE; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANEMIA; ANTIPYRINE; CHLORAMPHENICOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INDOCYANINE GREEN; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; IOTHALAMIC ACID; KIDNEY; LIVER CIRCULATION; MALE; MIDDLE AGED; SALMONELLA; TYPHOID FEVER;

EID: 0030758636     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.91     Document Type: Article

References (27)

1. Rowe, B., Threlfall, E. J. & Ward, L. R. (1987). Does chloramphenicol remain the drug of choice for typhoid? Epidemiology and Infection 98, 379-83.
2. Glazko, A. J., Dill, W. A., Kinkel, A. W., Goulet, J. R., Holloway, W. J. & Buchanan, R. A. (1977). Absorption and excretion of parenteral doses of chloramphenicol sodium succinate in comparison with peroral doses of chloramphenicol. Clinical Pharmacology and Therapeutics 21(1), Abstract, p. 104.
3. McCrumb, F. R., Snyder, M. J. & Hicken, W. J. (1958). The use of chloramphenicol acid succinate in the treatment of acute infections. In Antibiotics Annual, 1957-58, pp. 837-41. Medical Encyclopaedia, New York, NY.
4. Barrett, F. F., Taber, L. H., Morris, C. R., Stephenson, W. B., Clark, D. J. & Yow, M. D. (1972). A 12 year review of the antibiotic management of Haemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. Journal of Pediatrics 81, 370-7.
5. Bulos, N. K. (1972). Efficacy of intramuscular chloramphenicol in treatment of H. influenzae meningitis. Journal of Pediatrics 81, 416-7.
6. DuPont, H. L., Hornick, R. B., Weiss, C. F., Snyder, M. J. & Woodward, T. E. (1970). Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and rocky mountain spotted fever. New England Journal of Medicine 282, 53-7.
7. Shann, F., Linnemann, V., Mackenzie, A., Barker, J., Gratten, M. & Crinis, N. (1985). Absorption of chloramphenicol sodium succinate after intramuscular administration in children. New England Journal of Medicine 313, 410-4.
8. Ambrose, P. J. (1984). Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. Clinical Pharmacokinetics 9, 222-38.
9. Slaughter, R. L., Pieper, J. A., Cerra, B., Brodsky, B. & Koup, J. R. (1980). Chloramphenicol sodium succinate kinetics in critically ill patients. Clinical Pharmacology and Therapeutics 28, 69-77.
10. Koup, J. R., Lau, A. H., Brodsky, B. & Slaughter, R. L. (1979). Chloramphenicol pharmacokinetics in hospitalized patients. Antimicrobial Agents and Chemotherapy 15, 651-7.
11. Bhutta, Z. A., Naqvi, S. H., Durrani, S. & Suria, A. (1991) Chloramphenicol therapy of typhoid fever and its relationship to hepatic dysfunction. Journal of Tropical Pediatrics 37, 320-2.
12. Hall, P. M. & Rolin, H. (1995). Iothalamate clearance and its use in large-scale clinical trials. Current Opinion in Nephrology and Hypertension 4, 510-3.
13. Mclean, A., du Souich, P. & Gibaldi, M. (1979). Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease - a hypothesis. Clinical Pharmacology and Therapeutics 25, 161-6.
14. Cowan, S. T. (1974). Cowan and Steel's Manual for the Identification of Medical Bacteria, 2nd edn, Cambridge University Press, London.
15. National Committee for Clinical Laboratory Standards. (1984). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard M2-A3. ANSI/NCCLS, Villanova, PA.
16. Miller, S. I., Hohman, E. L. & Pegues, D. A. (1995). Salmonella (including Salmonella typhi). In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 2013-33. Churchill Livingstone, New York, NY.
17. Petersdorf, S. H., Raisys, V. A. & Opheim, K. E. (1979). Micro-scale method for liquid-chromatographic determination of chloramphenicol in serum. Clinical Chemistry 25, 1300-2.
18. Grainger, S. L., Keeling, P. W., Brown, I. M., Mangold, J. H. & Thompson, R. P. (1983). Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clinical Science 64, 207-12.
19. Davis, R. L., Koup, J. R., Williams-Warren, J., Weber, A., Heggen, L., Stempel, D. et al. (1987). Pharmacokinetics of ciprofloxacin in cystic fibrosis. Antimicrobial Agents and Chemotherapy, 31, 915-9.
20. Ciocatto, E. & Marchiaro, G. (1967). Chloramphenicol in resuscitation and cardiac surgery. Postgraduate Medical Journal 43, Suppl., 90-3.
21. Ross, S., Puig, J. R. & Zaremba, E. A. (1958). Chloramphenicol acid succinate (sodium salt): some preliminary clinical and laboratory observations in infants and children. In Antibiotics Annual, 1957-58, pp. 803-19. Medical Encyclopaedia, New York, NY.
22. Cockshott, W. P., Thompson, G. T., Hewlett, L. J. & Seeley, E. T. (1982). Intramuscular or intralipomatous injections? New England Journal of Medicine 307, 356-8.
23. Smith, A. L. & Weber, A. (1983). Pharmacology of chloramphenicol. Pediatric Clinics of North America 30, 209-36.
24. Mulhall, A., de Louvois, J. & Hurley, R. (1983). The pharmacokinetics of chloramphenicol in the neonate and young infant. Journal of Antimicrobial Chemotherapy 12, 629-39.
25. Gibaldi, M. (1991). Biopharmaceutics and Clinical Pharmacokinetics, 4th edn. Lea and Febiger, Philadelphia, PA.
26. Narang, A. P., Datta, D. V., Nath, N. & Mathur, V. S. (1981). Pharmacokinetic study of chloramphenicol in patients with liver disease. European Journal of Clinical Pharmacology 20, 479-83.
27. Wenk, M., Vozeh, S. & Follath, F. (1984). Serum level monitoring of antibacterial drugs. A review. Clinical Pharmacokinetics 9, 475-92.